DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Radhakrishnan V, Pai V, Rajaraman S. et al.
Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: an open-label, randomized phase 3 trial.
Pediatr Blood Cancer 2020;
67 (09) e28532
DOI: 10.1002/pbc.28532.
We do not assume any responsibility for the contents of the web pages of other providers.